feed,title,long_url,short_url
Benzinga,"Revlimid Generic Competition, Forex Impacts Bristol Myers' Q3 Sales; Reaffirms FY22 Guidance",https://benzinga.com/general/biotech/22/10/29410923/revlimid-generic-competition-forex-impacts-bristol-myers-q3-sales-reaffirms-fy22-guidance,https://bit.ly/3SwWbkc
Benzinga,Investor Sentiment Improves As Wall Street Rises For Third Straight Session,https://benzinga.com/news/earnings/22/10/29411801/investor-sentiment-improves-as-wall-street-rises-for-third-straight-session,https://bit.ly/3SDA9Mw
